• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胆囊癌切除术中淋巴结清扫生存获益列线图的构建与验证

Development and validation of a nomogram for survival benefit of lymphadenectomy in resected gallbladder cancer.

作者信息

Chen Mingyu, Lin Jian, Cao Jiasheng, Zhu Hepan, Zhang Bin, Wu Angela, Cai Xiujun

机构信息

Department of General Surgery, Sir Run-Run Shaw Hospital, Zhejiang University, Hangzhou 310016, China.

Key Laboratory of Endoscopic Technique Research of Zhejiang Province, Sir Run-Run Shaw Hospital, Zhejiang University, Hangzhou 310016, China.

出版信息

Hepatobiliary Surg Nutr. 2019 Oct;8(5):480-489. doi: 10.21037/hbsn.2019.03.02.

DOI:10.21037/hbsn.2019.03.02
PMID:31673537
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6791978/
Abstract

BACKGROUND

Due to absence of large, prospective, randomized, clinical trial data, the potential survival benefit of lymphadenectomy with different number of regional lymph nodes (LNs) remains controversial. We aim to create a predicting model to help estimate individualized potential survival benefit of lymphadenectomy with more regional LNs for patients with resected gallbladder cancer (GBC).

METHODS

Patients with resected GBC were selected from the Surveillance, Epidemiology, and End Results database who were diagnosed between 2004 and 2014. Covariates included age, race, sex, grade, histological stage, tumor sizes and receipt of non-primary surgery. Two types of multivariate survival regression models were constructed and compared. The best model performance was tested by the external validation data from our hospital.

RESULTS

A total of 1,669 patients met the inclusion criteria for this study. The lognormal survival model showed the best performance and was tested by the external validation data, including 193 patients with resected GBC from our hospital. Nomograms, which based on the accelerated failure time parametric survival model, were built to estimate individualized survival. C-index, was up to 0.754 and 0.710 in internal validation for more and less regional LNs removed, respectively. Both of internal and external calibration curves showed good agreement between predicted and observed outcomes in the 1-, 3-, and 5-year overall survival (OS).

CONCLUSIONS

A predicting model can be used as a decision model to predict which patients may obtain benefit from lymphadenectomy with more regional LNs.

摘要

背景

由于缺乏大型、前瞻性、随机临床试验数据,不同区域淋巴结(LN)数量的淋巴结清扫术的潜在生存获益仍存在争议。我们旨在创建一个预测模型,以帮助估计行更多区域LN清扫术的胆囊癌(GBC)切除患者的个体化潜在生存获益。

方法

从监测、流行病学和最终结果数据库中选取2004年至2014年期间诊断为GBC且已接受手术切除的患者。协变量包括年龄、种族、性别、分级、组织学分期、肿瘤大小以及是否接受非初次手术。构建并比较了两种多变量生存回归模型。通过我院的外部验证数据对最佳模型性能进行了测试。

结果

共有1669例患者符合本研究的纳入标准。对数正态生存模型表现最佳,并通过外部验证数据进行了测试,其中包括我院193例接受GBC切除的患者。基于加速失效时间参数生存模型构建了列线图,以估计个体化生存情况。在内部验证中,对于切除更多和更少区域LN的情况,C指数分别高达0.754和0.710。内部和外部校准曲线均显示,在1年、3年和5年总生存(OS)方面,预测结果与观察结果之间具有良好的一致性。

结论

预测模型可作为一种决策模型,用于预测哪些患者可能从行更多区域LN清扫术中获益。

相似文献

1
Development and validation of a nomogram for survival benefit of lymphadenectomy in resected gallbladder cancer.胆囊癌切除术中淋巴结清扫生存获益列线图的构建与验证
Hepatobiliary Surg Nutr. 2019 Oct;8(5):480-489. doi: 10.21037/hbsn.2019.03.02.
2
Nomogram for predicting the benefit of adjuvant chemoradiotherapy for resected gallbladder cancer.预测可切除胆囊癌辅助放化疗获益的列线图。
J Clin Oncol. 2011 Dec 10;29(35):4627-32. doi: 10.1200/JCO.2010.33.8020. Epub 2011 Nov 7.
3
Effect of lymphadenectomy on the prognosis for N0 gallbladder carcinoma patients: A study based on SEER database.基于 SEER 数据库的淋巴结清扫术对 N0 期胆囊癌患者预后的影响研究。
Cancer Med. 2021 Oct;10(20):7136-7143. doi: 10.1002/cam4.4250. Epub 2021 Sep 14.
4
A Nomogram for Prediction of Overall Survival in Patients with Node-negative Gallbladder Cancer.预测淋巴结阴性胆囊癌患者总生存期的列线图
J Cancer. 2019 Jun 2;10(14):3246-3252. doi: 10.7150/jca.30046. eCollection 2019.
5
Nomogram Based on Log Odds of Positive Lymph Nodes Predicting Cancer-Specific Survival in Patients With T3 and T4 Gallbladder Cancer After Radical Resection.基于阳性淋巴结对数优势比的列线图预测T3和T4期胆囊癌患者根治性切除术后的癌症特异性生存情况
Front Surg. 2021 Oct 27;8:675661. doi: 10.3389/fsurg.2021.675661. eCollection 2021.
6
Nomogram to predict overall survival after gallbladder cancer resection in China.中国胆囊癌切除术后总生存预测列线图。
World J Gastroenterol. 2018 Dec 7;24(45):5167-5178. doi: 10.3748/wjg.v24.i45.5167.
7
Development and external validation of a nomogram for predicting the effect of tumor size on cancer-specific survival of resected gallbladder cancer: a population-based study.预测肿瘤大小对胆囊癌切除术后癌症特异性生存影响的列线图的开发与外部验证:一项基于人群的研究
Int J Clin Oncol. 2021 Jun;26(6):1120-1129. doi: 10.1007/s10147-021-01891-2. Epub 2021 Mar 5.
8
A Novel Staging System to Forecast the Cancer-Specific Survival of Patients With Resected Gallbladder Cancer.一种预测胆囊癌切除患者癌症特异性生存的新型分期系统。
Front Oncol. 2020 Jul 28;10:1281. doi: 10.3389/fonc.2020.01281. eCollection 2020.
9
Prediction model for estimating the survival benefit of adjuvant radiotherapy for gallbladder cancer.评估胆囊癌辅助放疗生存获益的预测模型
J Clin Oncol. 2008 May 1;26(13):2112-7. doi: 10.1200/JCO.2007.14.7934. Epub 2008 Mar 31.
10
Preoperative serum fibrinogen as a valuable predictor in the nomogram predicting overall survival of postoperative patients with gallbladder cancer.术前血清纤维蛋白原作为预测胆囊癌术后患者总生存的列线图中的一个有价值的预测指标。
J Gastrointest Oncol. 2021 Aug;12(4):1661-1672. doi: 10.21037/jgo-21-357.

引用本文的文献

1
Identification of publication characteristics and research trends in the management of gallbladder cancer.胆囊癌管理领域的出版物特征及研究趋势识别
ILIVER. 2022 Jul 14;1(2):127-138. doi: 10.1016/j.iliver.2022.06.004. eCollection 2022 Jun.
2
Prognostic roles nutritional index in patients with resectable and advanced biliary tract cancers.营养指标在可切除及进展期胆管癌患者中的预后作用
World J Gastroenterol. 2025 Feb 14;31(6):97697. doi: 10.3748/wjg.v31.i6.97697.
3
A Novel Clinically Prognostic Stratification Based on Prognostic Nutritional Index Status and Histological Grade in Patients With Gallbladder Cancer After Radical Surgery.基于预后营养指数状态和组织学分级的胆囊癌根治术后患者新型临床预后分层
Front Nutr. 2022 May 4;9:850971. doi: 10.3389/fnut.2022.850971. eCollection 2022.
4
Comparison of Outcomes After Primary Laparoscopic Versus Open Approach for T1b/T2 Gallbladder Cancer.T1b/T2期胆囊癌初次腹腔镜手术与开放手术治疗效果的比较
Front Oncol. 2021 Oct 28;11:758319. doi: 10.3389/fonc.2021.758319. eCollection 2021.
5
Prognostic Value of the Albumin-to-γ-glutamyltransferase Ratio for Gallbladder Cancer Patients and Establishing a Nomogram for Overall Survival.白蛋白与γ-谷氨酰转移酶比值对胆囊癌患者的预后价值及建立总生存列线图
J Cancer. 2021 May 13;12(14):4172-4182. doi: 10.7150/jca.49242. eCollection 2021.
6
Development and Validation of a Nomogram for Predicting Survival in Gallbladder Cancer Patients With Recurrence After Surgery.预测胆囊癌术后复发患者生存的列线图的开发与验证
Front Oncol. 2021 Jan 11;10:537789. doi: 10.3389/fonc.2020.537789. eCollection 2020.
7
Preoperative Immune Prognostic Index Can Predict the Clinical Outcomes of Patients with Gallbladder Cancer: Single-Center Experience.术前免疫预后指数可预测胆囊癌患者的临床结局:单中心经验
Cancer Manag Res. 2020 Nov 25;12:12137-12150. doi: 10.2147/CMAR.S271044. eCollection 2020.
8
Comparison of the Prognostic Value of Platelet-Related Indices in Biliary Tract Cancer Undergoing Surgical Resection.比较血小板相关指标在接受手术切除的胆道癌患者中的预后价值。
Cancer Res Treat. 2021 Apr;53(2):528-540. doi: 10.4143/crt.2020.833. Epub 2020 Nov 23.
9
Integrated analysis of serum lipid profile for predicting clinical outcomes of patients with malignant biliary tumor.血清脂质谱综合分析预测恶性胆道肿瘤患者的临床结局。
BMC Cancer. 2020 Oct 9;20(1):980. doi: 10.1186/s12885-020-07496-8.
10
γ-glutamyl transferase-to-platelet ratio based nomogram predicting overall survival of gallbladder carcinoma.基于γ-谷氨酰转移酶与血小板比值的列线图预测胆囊癌的总生存期
World J Gastrointest Oncol. 2020 Sep 15;12(9):1014-1030. doi: 10.4251/wjgo.v12.i9.1014.

本文引用的文献

1
Systematic review of management of incidental gallbladder cancer after cholecystectomy.胆囊切除术后偶然发现的胆囊癌的处理:系统综述。
Br J Surg. 2019 Jan;106(1):32-45. doi: 10.1002/bjs.11035.
2
Nomogram to predict overall survival after gallbladder cancer resection in China.中国胆囊癌切除术后总生存预测列线图。
World J Gastroenterol. 2018 Dec 7;24(45):5167-5178. doi: 10.3748/wjg.v24.i45.5167.
3
Research gaps and unanswered questions in gallbladder cancer.胆囊癌的研究空白与未解决的问题。
HPB (Oxford). 2018 Aug;20(8):685-686. doi: 10.1016/j.hpb.2018.03.006. Epub 2018 May 18.
4
Establishment of a Gallbladder Cancer-Specific Survival Model to Predict Prognosis in Non-metastatic Gallbladder Cancer Patients After Surgical Resection.建立胆囊癌特异性生存模型预测手术切除后非转移性胆囊癌患者的预后。
Dig Dis Sci. 2018 Sep;63(9):2251-2258. doi: 10.1007/s10620-018-5103-7. Epub 2018 May 8.
5
Pathologic and Prognostic Implications of Incidental Nonincidental Gallbladder Cancer: A 10-Institution Study from the United States Extrahepatic Biliary Malignancy Consortium.偶然与非偶然胆囊癌的病理及预后意义:来自美国肝外胆管恶性肿瘤联盟的一项10机构研究。
Am Surg. 2017 Jul 1;83(7):679-686.
6
Nomograms for preoperative prediction of axillary nodal status in breast cancer.用于乳腺癌腋窝淋巴结状态术前预测的列线图。
Br J Surg. 2017 Oct;104(11):1494-1505. doi: 10.1002/bjs.10583. Epub 2017 Jul 18.
7
A Nomogram based on Inflammatory Factors C-Reactive Protein and Fibrinogen to Predict the Prognostic Value in Patients with Resected Non-Small Cell Lung Cancer.基于炎症因子C反应蛋白和纤维蛋白原的列线图预测非小细胞肺癌切除患者的预后价值
J Cancer. 2017 Feb 25;8(5):744-753. doi: 10.7150/jca.17423. eCollection 2017.
8
Proposed Nomogram Predicting the Individual Risk of Malignancy in the Patients With Branch Duct Type Intraductal Papillary Mucinous Neoplasms of the Pancreas.预测胰腺分支导管型导管内乳头状黏液性肿瘤患者个体恶性风险的拟用列线图
Ann Surg. 2017 Dec;266(6):1062-1068. doi: 10.1097/SLA.0000000000001985.
9
Development of a Nomogram for Predicting Severe Neutropenia Associated With Docetaxel-Based Chemotherapy in Patients With Castration-Resistant Prostate Cancer.用于预测去势抵抗性前列腺癌患者基于多西他赛化疗相关严重中性粒细胞减少症的列线图的开发。
Clin Genitourin Cancer. 2017 Feb;15(1):176-181. doi: 10.1016/j.clgc.2016.05.012. Epub 2016 May 27.
10
Development of a nomogram combining clinical staging with (18)F-FDG PET/CT image features in non-small-cell lung cancer stage I-III.非小细胞肺癌I-III期临床分期与(18)F-FDG PET/CT图像特征相结合的列线图的开发
Eur J Nucl Med Mol Imaging. 2016 Jul;43(8):1477-85. doi: 10.1007/s00259-016-3325-5. Epub 2016 Feb 20.